Ligament Healing

Ligament healing follows similar principles to tendon healing, with important differences that depend on where the ligament sits. Extra-articular ligaments such as the MCL heal reliably. Intra-articular ligaments such as the ACL do not heal spontaneously, and need surgical reconstruction if normal function is to be restored.

Why it matters. Knowing why some ligaments heal and others do not is what guides treatment. MCL injuries are typically managed non-operatively, ACL injuries are reconstructed in active patients, and the biology of healing informs rehabilitation protocols.

View larger

Healing runs through three overlapping phases, similar to those of tendon.

Inflammatory phase (days 0-7). Injury triggers an inflammatory response. A haematoma forms and serves as the scaffold for healing, and inflammatory cells arrive and release cytokines and growth factors. This phase is essential for initiating repair, and it is the step that fails inside the joint, for the reasons compared in the MCL and ACL section below.

Proliferative phase (weeks 1-6). Fibroblasts migrate into the healing zone and proliferate, granulation tissue forms, and synthesis of type III collagen begins, laid down as thin, disorganised fibres. The tissue is highly cellular and disorganised, and its mechanical strength is minimal.

Remodelling phase (week 6 to years). Type III collagen is gradually replaced by thick, organised type I collagen. The fibres align along lines of stress, cross-links form between collagen molecules and cellularity falls. The mechanical properties improve but never return to normal.

The end result is weaker than the original. A healed ligament achieves only part of its normal tensile strength, conventionally quoted as 50-70%, although that band comes from animal (rabbit MCL) studies and no human measurement is cited here. Stiffness is reduced too. An increased cross-sectional area compensates, and functional recovery is possible.

View larger

Immobilisation is harmful. Prolonged immobilisation produces a disorganised matrix with randomly oriented collagen, adhesions, reduced matrix turnover, and a loss of tensile strength and stiffness. It also causes resorption and weakening at the bone–ligament insertion, so after a period of immobilisation the insertion becomes the weak link.

Controlled cyclic loading is beneficial. Mechanical stress is a signal. It aligns fibroblasts and collagen fibres along the lines of stress, a soft-tissue analogue of Wolff's law, and promotes larger-diameter fibrils and better cross-linking. Tensile strength and stiffness rise and adhesions are reduced, so loading improves the quality and organisation of the healing scar rather than only its bulk.

The dose matters: an "envelope of function". Too little load gives a weak, disorganised scar, and appropriate controlled load optimises organised healing. Excessive load too early causes gap formation, elongation or re-rupture.

What rehabilitation takes from this. The dose-response is why rehabilitation uses early protected range of motion and graduated functional loading. It is also the rationale for hinged bracing and for internal-brace augmentation, which shares load to protect a repair through the vulnerable phase, though whether the brace also stress-shields the healing ligament remains debated (see Controversies). General bone mechanotransduction is developed in the osteocytes-mechanotransduction topic, and the viscoelastic behaviour of ligament in the viscoelasticity topic.

View larger

When a ligament injury fails to recover as expected, the differential is broader than the index injury. Separate a ligament that biologically does not heal, such as the ACL, from a missed associated injury or a systemic cause of impaired healing.

The MCL heals. In most cases the MCL heals predictably with conservative management. Its extra-articular position allows a haematoma to form and be contained, and the periligamentous tissues provide a blood supply. The healing MCL is enlarged but functional.

Managing the MCL. Management is protected motion in a hinged brace, with valgus stress protected during healing, followed by rehabilitation. Surgery is rarely needed for an isolated MCL injury. Functional recovery is expected, and most patients return to function.

View larger

The ACL does not heal spontaneously. Its synovial environment is hostile to healing, and it lacks the capacity for intrinsic repair seen in extra-articular ligaments. The factors that separate it from the MCL are set side by side below.

Why reconstruct. Leaving the knee ACL-deficient leads to instability and a risk of secondary meniscal and chondral damage. Reconstruction replaces the ligament's function with a graft, and is required to restore stability in active patients who want to return to pivoting activities.

Repair revisited. ACL repair, by primary suture, internal bracing, or scaffold bridging as in BEAR, is being revisited for proximal or midsubstance tears with good tissue. Reconstruction remains the standard for most complete tears in pivoting athletes. The BEAR II trial and the primary-repair series are in the Evidence Base, and Controversies sets out why they have not displaced reconstruction.

View larger

View larger

View larger

View larger

View larger

View larger

Because the torn ACL is replaced with a graft, the obvious follow-up question is how the graft heals. A tendon graft does not stay tendon: it remodels into an ACL-like structure through ligamentisation, in overlapping phases.

Early avascular phase (first weeks). The free graft is initially avascular, with central necrosis and falling cellularity. Mechanically it depends on its initial fixation while its intrinsic material strength declines.

Revascularisation and cellular repopulation (around 6 to 12 weeks). Host cells and vessels from the synovium and fat pad invade the graft. This is the window in which the graft is mechanically weakest, the "ligamentisation valley", and it is the biological reason rehabilitation is protected and graduated rather than aggressive in the first few months.

Remodelling and maturation (months to over a year). Collagen realigns, crimp returns and cellularity normalises, and the graft becomes ACL-like. As with native ligament scar it never fully matches the original ACL, with smaller fibrils and incomplete cross-link maturation, and maturation can take well over a year.

View larger

Healing in the tunnel. The graft must also integrate within the bone tunnel, and the interface depends on the graft. Soft-tissue grafts (for example hamstring) heal by an indirect, fibrovascular interface, with Sharpey-like fibres maturing over weeks to months. Bone-block grafts (bone–patellar tendon–bone) achieve faster, more direct bone-to-bone union. This difference is one driver of graft choice and of how early the construct can be loaded. Enthesis and insertion-site biology is developed in the tendon-bone-interface-enthesis topic.

View larger

View larger

View larger

Global Epidemiology

• ACL injuries occur in roughly 30 to 80 per 100,000 person-years, concentrated in 15 to 45-year-olds and in pivoting/cutting sports; females carry a several-fold higher sport-adjusted risk.
• Isolated MCL injury is the most common knee ligament injury overall and the great majority are managed non-operatively with reliable healing.

Side-by-Side Guidance

Registry & Outcome Signals

• National ligament/ACL registries (e.g. Scandinavian and UK datasets) track graft choice, revision and reinjury, informing graft selection and rehabilitation rather than healing biology per se.
• Emerging BEAR and primary-repair data are not yet captured at registry scale, so practice change should remain cautious.

High- vs Limited-Resource Practice

• Well-resourced settings: ready access to MRI, arthroscopic reconstruction, and increasingly repair/BEAR in selected patients, with supervised criteria-based rehabilitation.
• Limited-resource settings: non-operative management and bracing dominate; isolated MCL injuries heal reliably without surgery, and structured rehabilitation is the highest-value intervention where arthroscopy is scarce.

• Does the ACL truly never heal? The BEAR II trial shows engineered intra-articular healing is possible in selected young patients, but the numerically higher reinjury rate, narrow inclusion (complete midsubstance tears treated within ~45 days), and limited long-term and registry data mean reconstruction stays the default for most pivoting athletes.
• Patient selection for primary repair. Excellent outcomes are confined to proximal avulsion tears with good tissue. There is no validated, reproducible intra-operative grading of tissue quality, so selection remains subjective and operator-dependent.
• Internal bracing — protection or stress-shielding? Suture tape augmentation may protect an early repair, but it could also stress-shield the healing ligament and alter its remodelling; the BEAR II reinjury signal and small repair cohorts leave this unresolved.
• Biological augmentation (PRP, growth factors, scaffolds). Animal data (PDGF-BB, collagen-platelet composite) are encouraging, but human evidence that PRP meaningfully improves ligament healing or outcome remains inconsistent.
• Grade III MCL and combined injuries. Whether high-grade or distal (superficial-MCL avulsion / Stener-like) MCL tears, and the MCL component of combined ACL/MCL injuries, need repair or augmentation rather than bracing is still debated.